Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the Gbd 2019 Study
Masih Tajdini
Masih Tajdini

Associate Professor of Cardiology

Department Cardiology

School of Medicine

Tehran Heart Research Center

Tehran University of Medical Sciences

All Documents
1. Heart Surgery Over Two Decades: What We Have Learned About Results and Changing Risks, BMC cardiovascular disorders (2024)
2. Risk Factor Profile and Outcomes of Premature Acute Coronary Syndrome After Percutaneous Coronary Intervention: A 1-Year Prospective Design, Clinical Cardiology (2024)
3. Risk Factor Profile and Outcomes of Premature Acute Coronary Syndrome After Percutaneous Coronary Intervention: A 1-Year Prospective Design, Clinical Cardiology (2024)
4. Sex-Based Association Between High-Density Lipoprotein Cholesterol and Adverse Outcomes After Coronary Artery Bypass Grafting, BMC Cardiovascular Disorders (2024)
5. Age and Gender Differences of Basic Electrocardiographic Values and Abnormalities in the General Adult Population; Tehran Cohort Study, BMC Cardiovascular Disorders (2023)
6. Association Between Vitamin D Deficiency and Vasovagal Syncope: A Systematic Review and Meta-Analysis, Clinical Cardiology (2023)
7. Brain Mri and Eeg Overemployment in Patients With Vasovagal Syncope: Results From a Tertiary Syncope Unit, BMC Cardiovascular Disorders (2023)
8. Clinical Associations of Injuries Caused by Vasovagal Syncope: A Cohort Study From a Tertiary Syncope Unit, Journal of the American Heart Association (2023)
9. Epidemiological, Clinical, and Economic Burden of Myocardial Infarction Patients in Iran During the Covid-19 Pandemic, IJC Heart and Vasculature (2023)
10. Epidemiology and Prevalence of Tobacco Use in Tehran; a Report From the Recruitment Phase of Tehran Cohort Study, BMC Public Health (2023)
11. In-Hospital and 1-Year Outcomes of Patients Without Modifiable Risk Factors Presenting With Acute Coronary Syndrome Undergoing Pci: A Sex-Stratified Analysis, Frontiers in Cardiovascular Medicine (2023)
12. In-Hospital and 1-Year Outcomes of Patients Without Modifiable Risk Factors Presenting With Acute Coronary Syndrome Undergoing Pci: A Sex-Stratified Analysis, Frontiers in Cardiovascular Medicine (2023)
13. Left Atrial Function Evaluation by 2D Speckle-Tracking Echocardiography in Patients With Vasovagal Syncope, PACE - Pacing and Clinical Electrophysiology (2023)
14. Pharmacologic Prevention of Recurrent Vasovagal Syncope: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials, Heart Rhythm (2023)
15. Bmi Modifies Hdl-C Effects on Coronary Artery Bypass Grafting Outcomes, Lipids in Health and Disease (2022)
16. Cardiovascular Health Effects of Wearing a Particulate-Filtering Respirator to Reduce Particulate Matter Exposure: A Randomized Crossover Trial, Journal of Human Hypertension (2022)
17. Clinical Presentation, Disease Course, and Outcome of Covid-19 in Hospitalized Patients With and Without Pre-Existing Cardiac Disease: A Cohort Study Across 18 Countries, European Heart Journal (2022)
18. Compression Stockings for Treating Vasovagal Syncope (Comforts-Ii) Trial: Rationale and Design of a Triple-Blind, Multi-Center, Randomized Controlled Trial, American Heart Journal (2022)
19. Compression Stockings for Treating Vasovagal Syncope (Comforts-Ii) Trial: Rationale and Design of a Triple-Blind, Multi-Center, Randomized Controlled Trial, American Heart Journal (2022)
20. Cost-Effectiveness of Sacubitril/Valsartan Compared With Enalapril in Patients With Heart Failure With Reduced Ejection Fraction: A Systematic Review, Journal of Tehran University Heart Center (2022)
21. Evaluation of the Practice Guideline Used for Rule-Out of Myocardial Infarction at a Tertiary Cardiology Center, Critical Pathways in Cardiology (2022)
22. Hospitalization, Major Complications and Mortality in Acute Myocardial Infarction Patients During the Covid-19 Era: A Systematic Review and Meta-Analysis, IJC Heart and Vasculature (2022)
23. Implementation of Supervised Physical Training to Reduce Vasovagal Syncope Recurrence: A Randomized Controlled Trial, Journal of Cardiovascular Electrophysiology (2022)
24. Off-Pump Versus On-Pump Coronary Artery Bypass Graft Surgery Outcomes in Patients With Severe Left Ventricle Dysfunction: Inverse Probability Weighted Study, BMC Cardiovascular Disorders (2022)
25. Preprocedural Colchicine in Patients With Acute St-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: A Randomized Controlled Trial (Podcast-Pci), Journal of Cardiovascular Pharmacology (2022)
26. Prognostic Significance of Positive Family History in Outcomes After Coronary Artery Bypass Grafting: Do We Need to Update Our Assumptions?, Journal of Cardiothoracic Surgery (2022)
27. Role of Personalized Medicine in Cardiovascular Disease: A Narrative Review, Koomesh (2022)
28. Sex Difference in the Risk Factor Distributions and Outcomes After Coronary Artery Bypass Graft Surgery in the Young Population, European Journal of Cardio-thoracic Surgery (2022)
29. The Role of Compression Stockings in the Treatment of Patients With Vasovagal Syncope, Journal of Babol University of Medical Sciences (2022)
30. Atomoxetine As an Adjunct to Nonpharmacological Treatments for Preventing Vasovagal Attacks in Patients With Recurrent Vasovagal Syncope: A Pilot Randomized-Controlled Trial, IJC Heart and Vasculature (2021)
31. Clinical Implications and Indicators of Mortality Among Patients Hospitalized With Concurrent Covid-19 and Myocardial Infarction, Turk Kardiyoloji Dernegi Arsivi (2021)
32. Comparison of Outcomes With Midodrine and Fludrocortisone for Objective Recurrence in Treating Syncope (Comforts Trial): Rationale and Design for a Multi-Center Randomized Controlled Trial, American Heart Journal (2021)
33. Comparison of Outcomes With Midodrine and Fludrocortisone for Objective Recurrence in Treating Syncope (Comforts Trial): Rationale and Design for a Multi-Center Randomized Controlled Trial, American Heart Journal (2021)
34. Comparison of Trinitroglycerin and Adenosine As Provocative Agents for Head-Up Tilt Test in Patients With Unexplained Syncope: A Semi-Crossover Randomized Clinical Trial With Prospective Follow-Up, Journal of Interventional Cardiac Electrophysiology (2021)
35. Cost-Effectiveness of Cardiac Resynchronization Therapy Plus an Implantable Cardioverter-Defibrillator in Patients With Heart Failure: A Systematic Review, Cost Effectiveness and Resource Allocation (2021)
36. Cost-Effectiveness of Endovascular Versus Open Repair of Abdominal Aortic Aneurysm: A Systematic Review, Cardiovascular Drugs and Therapy (2021)
37. Differences in the 2020 Esc Versus 2019 Acc/Aha/Hrs Guidelines on Atrial Fibrillation, European heart journal (2021)
38. Fluid Management in Acute Cardiac Condition and Superimposed Covid-19 Infection. Do We Need a Careful Revision?, Caspian Journal of Internal Medicine (2021)
39. Intrapericardial Solitary Fibrous Tumor: A Case Report and Review of Literature, Echocardiography (2021)
40. Mid-Term Outcomes of Off-Pump Versus On-Pump Coronary Artery Bypass Graft Surgery; Statistical Challenges in Comparison, BMC Cardiovascular Disorders (2021)
41. Personalized Medicine in Cardiovascular Disease: Review of Literature, Journal of Diabetes and Metabolic Disorders (2021)
42. Prognostic Impact of Prediabetes on Patient Outcomes After Coronary Artery Bypass Grafting: A Single-Center Cohort Study, Critical Pathways in Cardiology (2021)
43. Social and Economic Costs and Health-Related Quality of Life in Patients With Acute Coronary Syndrome, Value in Health Regional Issues (2021)
44. Tehran Cohort Study (Tecs) on Cardiovascular Diseases, Injury, and Mental Health: Design, Methods, and Recruitment Data, Global Epidemiology (2021)
45. The Syncope Unit of Tehran Heart Center, European Heart Journal (2021)
46. Time for Clinicians to Revisit Their Perspectives on C-Statistic, European Heart Journal (2021)
47. A Systematic Review of the Cost-Effectiveness of Heart Valve Replacement With a Mechanical Versus Biological Prosthesis in Patients With Heart Valvular Disease, Heart Failure Reviews (2020)
48. Can Respirator Face Masks in a Developing Country Reduce Exposure to Ambient Particulate Matter?, Journal of Exposure Science and Environmental Epidemiology (2020)
49. Complicated Endocarditis With Bilateral Pseudoaneurysm Formation in a Patient With Valvular Heart Disease; [Valvuler Kalp Hastaligi Olan Hastada Bilateral Psodoanevrizma Ile Komplike Endokardit Olusumu], Turk Kardiyoloji Dernegi Arsivi (2020)
50. Cost-Effectiveness Analysis of Pcsk9 Inhibitors in Cardiovascular Diseases: A Systematic Review, Heart Failure Reviews (2020)
51. Diagnostic Accuracy of 64-Slice Computed Tomography Angiography in Patients With Chest Pain Vs. Spect in the Assessment of Significant Coronary Artery Disease: A Systematic Review and Meta-Analysis, Health Technology Assessment in Action (2020)
52. Five Insights From the Global Burden of Disease Study 2019, The Lancet (2020)
53. Five Insights From the Global Burden of Disease Study 2019, The Lancet (2020)
54. Global Age-Sex-Specific Fertility, Mortality, Healthy Life Expectancy (Hale), and Population Estimates in 204 Countries and Territories, 1950–2019: A Comprehensive Demographic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
55. Global Age-Sex-Specific Fertility, Mortality, Healthy Life Expectancy (Hale), and Population Estimates in 204 Countries and Territories, 1950–2019: A Comprehensive Demographic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
56. Global Burden of 369 Diseases and Injuries in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
57. Global Burden of 369 Diseases and Injuries in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
58. Global Burden of 87 Risk Factors in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
59. Global Burden of 87 Risk Factors in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
60. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the Gbd 2019 Study, Journal of the American College of Cardiology (2020)
61. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the Gbd 2019 Study, Journal of the American College of Cardiology (2020)
62. One-Year Outcome of Patients With Coronary Artery Ectasia Undergoing Percutaneous Coronary Intervention: Clinical Implications and Question Marks, Journal of Tehran University Heart Center (2020)
63. The Association of Statins for Secondary Prevention With Progression to Diabetes in Patients With Prediabetic State After Coronary Artery Bypass Graft Surgery: A Retrospective Cohort Study, Journal of Diabetes and its Complications (2020)
64. The Need for Permanent Pacemaker After Restoration of Conduction Following Atrioventricular Block: A Retrospective Cohort Study; [Atriyoventrikuler Blogu Takiben Iletimin Restorasyonu Sonrasi Kalici Kalp Pili Gereksinmesi: Geriye Donuk Bir Kohort Calismasi], Turk Kardiyoloji Dernegi Arsivi (2020)
65. Unusual Case of Tricuspid Atresia and Transposition of the Great Arteries Presenting With Aortic Dissection: A Rare Condition; [Olagandisi Trikuspit Atrezi Olgusu Ve Aort Diseksiyonu Ile Ortaya Cikan Buyuk Arterlerin Transpozisyonu: Nadir Bir Durum], Turk Kardiyoloji Dernegi Arsivi (2020)
66. Coronary Slow Flow Phenomenon and Microalbuminuria: Is There Any Relationship?; [Koroner Yavas Akim Fenomeni Ve Mikroalbuminuri: Herhangi Bir Iliski Var Mi?], Turk Kardiyoloji Dernegi Arsivi (2019)
67. Cost-Effectiveness of Coronary Artery Bypass Graft and Percutaneous Coronary Intervention Compared to Medical Therapy in Patients With Coronary Artery Disease: A Systematic Review, Heart Failure Reviews (2019)
68. Effects of High Dose Atorvastatin Before Elective Percutaneous Coronary Intervention on Highly Sensitive Troponin T and One Year Major Cardiovascular Events; a Randomized Clinical Trial, IJC Heart and Vasculature (2019)
69. Mid-Term Outcome and Prognosis of Prediabetic Patients After Coronary Artery Bypass Graft Surgery, Regardless of the First Month After Surgery, Critical Pathways in Cardiology (2019)
70. Predicting Serious Outcomes in Syncope Patients Using Data Mining Techniques, 2019 9th International Conference on Computer and Knowledge Engineering# ICCKE 2019 (2019)
71. A New Feasible Syncope Risk Score Appropriate for Emergency Department: A Prospective Cohort Study, Critical Pathways in Cardiology (2018)
72. Fluoxetine for Multiple Sclerosis, Cochrane Database of Systematic Reviews (2018)
73. Aortic Dissection and Cystinosis: Is There Any Relationship?, Cardiology in the Young (2017)
74. Association of Serum Gamma-Glutamyltransferase and Premature Coronary Artery Disease, Netherlands Heart Journal (2017)
75. Salivary B-Type Natriuretic Peptide: A New Method for Heart Failure Diagnosis and Follow-Up, Kardiologia Polska (2017)
76. Asymptomatic Interrupted Aortic Arch, Severe Tricuspid Regurgitation, and Bicuspid Aortic Valve in a 76-Year-Old Woman, Texas Heart Institute Journal (2016)
77. Focal Myopericarditis As a Rare But Important Differential Diagnosis of Myocardial Infarction; a Case Series, Emergency (2016)
78. Reversible Left Bundle Branch Block Should Be Mentioned in Cardiac Resynchronization Therapy; a Clinical Case Report, ARYA Atherosclerosis (2016)
79. Spontaneous Myopericarditis in a Patient Under Dexamethasone: A Double-Edged Sword?, Journal of the Saudi Heart Association (2015)